Boomray Pharmaceuticals Co., Ltd.
PrivateLast Round
Series A
Sep 2, 2022
Total Funding Raised
$43.2M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Boomray Pharmaceuticals Co., Ltd. operates in Healthcare & Life Sciences and is based in Suzhou. Its latest recorded funding round was a Series A round in September 2022.
Boomray Pharmaceuticals Co., Ltd. is a biotechnology company that develops innovative radioligand therapies for precision oncology diagnostics and therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical Imaging, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Boomray Pharmaceuticals Co., Ltd. Comparables
Compare Boomray Pharmaceuticals Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hangzhou Eli Radiopharma Co., Ltd. | 87% | |
| C-Ray Therapeutics | 85% | |
| Full-Life Technologies | 85% |
For institutional investors. Book with your work email.
Boomray Pharmaceuticals Co., Ltd. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Boomray Pharmaceuticals Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Puhua Capital | Series A |
| HongShan Capital Group (HSG) | Series A |
| Sunshine Riverhead Capital Investment Management Co., Ltd. | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 606% MoM.
- Apr 22, 2026
Monthly visitors increased 2221% MoM, reaching 1.7K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withSep 22, 2026
On Sep 22nd '26 in China, BoomRay Pharmaceutical Co., Ltd. and Novartis Pharmaceuticals Corporation enter an exclusive global license agreement for an undisclosed preclinical RLT asset, combining BoomRay Pharmaceutical Co., Ltd.'s discovery and development capabilities with Novartis Pharmaceuticals Corporation's global RLT expertise to pursue meaningful therapeutic benefit for patients worldwide.
For institutional investors. Book with your work email.
Boomray Pharmaceuticals Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Boomray Pharmaceuticals Co., Ltd.'s valuation, stock price, and market status.
Is Boomray Pharmaceuticals Co., Ltd. a public or private company?
Boomray Pharmaceuticals Co., Ltd. is a private company.
What is the current stock price of Boomray Pharmaceuticals Co., Ltd.?
Boomray Pharmaceuticals Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Boomray Pharmaceuticals Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Boomray Pharmaceuticals Co., Ltd. worth (valuation)?
Valuation information for Boomray Pharmaceuticals Co., Ltd. is not publicly available.
Can I buy Boomray Pharmaceuticals Co., Ltd. stock?
Boomray Pharmaceuticals Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Boomray Pharmaceuticals Co., Ltd.'s last funding round?
Boomray Pharmaceuticals Co., Ltd.'s most recent funding round was Series A on September 2, 2022.
Who are the main investors in Boomray Pharmaceuticals Co., Ltd.?
Key investors in Boomray Pharmaceuticals Co., Ltd. include HongShan Capital Group (HSG).
Will Boomray Pharmaceuticals Co., Ltd. IPO soon?
No public IPO plans have been announced for Boomray Pharmaceuticals Co., Ltd..
How can I track Boomray Pharmaceuticals Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Boomray Pharmaceuticals Co., Ltd.'s shares on secondary markets.